tiprankstipranks
Advertisement
Advertisement

AORT Stock Latest News

AORT Upcoming Earnings Report: What to Expect?
Pre-EarningsAORT Upcoming Earnings Report: What to Expect?
1d ago
AORT
Artivion added to Conviction List at Needham
PremiumThe Fly
Artivion added to Conviction List at Needham
16d ago
AORT
Artivion upgraded to Buy from Neutral at Ladenburg
PremiumThe Fly
Artivion upgraded to Buy from Neutral at Ladenburg
26d ago
AORT
Artivion’s PMA for Nexus Aortic Arch System approved by the FDA
PremiumThe Fly
Artivion’s PMA for Nexus Aortic Arch System approved by the FDA
29d ago
AORT
Artivion’s New Chord-X Mitral Valve Study Sets Stage for Long-Term Value
PremiumCompany Announcements
Artivion’s New Chord-X Mitral Valve Study Sets Stage for Long-Term Value
2M ago
AORT
Artivion Earnings Call Highlights Growth, Margin Momentum
PremiumCompany AnnouncementsArtivion Earnings Call Highlights Growth, Margin Momentum
3M ago
AORT
Artivion price target lowered to $48 from $51 at Canaccord
Premium
The Fly
Artivion price target lowered to $48 from $51 at Canaccord
3M ago
AORT
Artivion reports Q4 non-GAAP EPS 17c, consensus 18c
Premium
The Fly
Artivion reports Q4 non-GAAP EPS 17c, consensus 18c
3M ago
AORT
Artivion sees 2026 revenue $486M-$504M, consensus $490.19M
PremiumThe Fly
Artivion sees 2026 revenue $486M-$504M, consensus $490.19M
3M ago
AORT
AORT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
AORT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
AORT
Artivion: Positive Clinical Data and Pipeline Progress Support Sustained Growth and Buy Rating
PremiumRatings
Artivion: Positive Clinical Data and Pipeline Progress Support Sustained Growth and Buy Rating
3M ago
AORT
Artivion announces presentations of clinical data from Nexus and AMD trials
PremiumThe Fly
Artivion announces presentations of clinical data from Nexus and AMD trials
3M ago
AORT
Artivion: Strategic Growth, Market Expansion, and Long-Term Value Creation Drive Buy Rating
PremiumRatingsArtivion: Strategic Growth, Market Expansion, and Long-Term Value Creation Drive Buy Rating
5M ago
AORT
Artivion Inc. Reports Robust Earnings Amid Growth Challenges
Premium
Company Announcements
Artivion Inc. Reports Robust Earnings Amid Growth Challenges
6M ago
AORT
Artivion price target raised to $55 from $46 at Stifel
Premium
The Fly
Artivion price target raised to $55 from $46 at Stifel
6M ago
AORT
Artivion price target raised to $55 from $45 at Lake Street
PremiumThe Fly
Artivion price target raised to $55 from $45 at Lake Street
6M ago
AORT
Artivion price target raised to $50 from $40 at Oppenheimer
PremiumThe Fly
Artivion price target raised to $50 from $40 at Oppenheimer
6M ago
AORT
Artivion price target raised to $40 from $38 at Ladenburg
PremiumThe Fly
Artivion price target raised to $40 from $38 at Ladenburg
6M ago
AORT
Artivion price target raised to $51 from $50 at Canaccord
PremiumThe Fly
Artivion price target raised to $51 from $50 at Canaccord
6M ago
AORT
Artivion price target raised to $53 from $47 at Citizens JMP
PremiumThe FlyArtivion price target raised to $53 from $47 at Citizens JMP
6M ago
AORT
Artivion’s Strong Q3 Performance and Growth Prospects Justify Buy Rating
Premium
Ratings
Artivion’s Strong Q3 Performance and Growth Prospects Justify Buy Rating
6M ago
AORT
Artivion Inc. Reports Strong Q3 2025 Financial Results
Premium
Company Announcements
Artivion Inc. Reports Strong Q3 2025 Financial Results
6M ago
AORT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >